Hepatitis A, B, C: Clarissa Isidra D.Guiang BSN
Hepatitis A, B, C: Clarissa Isidra D.Guiang BSN
Hepatitis A(Infectious
hepatitis/Catarrhal jaundice)
*A
Period of Communicability
*Infected Patient is capable of transmitting the
organism from a week before until a week after the
appearance.
Mode of Transmission
The virus is transmitted through the fecal
oral pathway:
Pathology/ Pathogenesis
1. Following ingestion , HAV enters the bloodstream
through the epithelium of the oropharynx or intestines.
2. The blood carries the virus to its target the liver, where it
lives and multiples within the hepatocytes and Kupffer
cells.
3. Virions are secreted into the bile and released in stools.
HAV is excreted in large quantities approximately 11
days prior to the appearance of symptoms or anti HAV
IgM antibodies in the blood.
Clinical Manifestations
Complications
Progressive encephalophaty characterized by drowsiness
and cerebral palsy.
GIT bleeding progressing to stupor and later coma. Bleeding
is not responsive to parenteral vitamin K administration.
Clonus and hyper reflexia are later replaced by loss of deep
tendon reflexes.
Edema and ascitis
Aplastic anemia
Loss of corneal and papillary reflexes
Elevated arterial blood
Respiratory failure
Cerebrovascular collapse may be present
Diagnostic Procedure
Treatment Modalities
No specific treatment although bed rest is essential
Diet must be high in carbohydrates , low fat and low
protein
Patient must take vitamin supplements especially vit. B
complex.
IV theraphy is occasionally necessary.
Isoprinosine( methisoprenol) may enchance the cell
mediated immunity of T-lymphocytes.
Alkalies, Belldonna and anti emetics should be
administered to control dyspepsia and malaise.
Nursing Management
Patient must be isolated(enteric isolation)
Patient should be encourage to rest during acute and
symptomatic phase.
Patient nutritional status must be improved
Appropriate measure to minimize spread of disease
Observe patient MELENA and check stool for the presence of
blood
Provide optimum skin and oral care
Increased the ability to carry out activities
A. Encourage the pt. to limit activity when fatigued
B. Assist the client in planning periods of rest and activity
C. Encourage gradual resumption of activities and mild
exercise during recovery.
Etiologic Agent
Incubation Period
Mode of Transmission
Clinical Manifestation
1. PRODOMAL PERIOD
-the time during which a disease process has begun but
is not yet clinically manifest.
a. Fever , malaise, anorexia
b. nausea , vomiting abdominal discomfort, fever , chills
c. jaundice, dark urine and pale stools
d. recovery is indicated by a decline of fever and
improved appetite.
2. FULMINANT HEPATITIS- may be fatal and manifested
by severe symptoms like ascites and bleeding.
Diagnostic Procedure
SGOT,SGPT,ALT
Prevention
Hepatitis C
an infectious disease affecting primarily the liver, caused
by the hepatitis C virus (HCV). The infection is often
asymptomatic, but chronic infection can lead to scarring of
the liver and ultimately to cirrhosis, which is generally
apparent after many years. In some cases, those with
cirrhosis will go on to develop liver failure, liver cancer, or
life-threatening esophageal and gastric varices. spread
primarily by blood-to-blood contact associated with
intravenous drug use, poorly sterilized medical equipment,
and transfusions. An estimated 150200 million people
worldwide are infected with hepatitis C.The existence of
hepatitis C (originally identifiable only as a type of non-A
non-B hepatitis) was suggested in the 1970s and proven in
1989. Hepatitis C infects only humans and chimpanzees.
Acute infection
Symptoms are generally mild and vague, including a
decreased appetite, fatigue, nausea, muscle or joint
pains, and weight loss and rarely does acute liver failure
result. Most cases of acute infection are not associated
with jaundice.The infection resolves spontaneously in
1050% of cases, which occurs more frequently in
individuals who are young and female.
Incubation
15-160 days
Adults 40-59 yrs.old
Chronic infection
Treatment/medications
HCV induces chronic infection in 5080% of infected
persons. Approximately 4080% of these clear with
treatment. In rare cases, infection can clear without
treatment.Those with chronic hepatitis C are advised to
avoid alcohol and medications toxic to the liver, and to
be vaccinated for hepatitis A and hepatitis B. Ultrasound
surveillance for hepatocellular carcinoma is
recommended in those with accompanying cirrhosis.
Mode of transmission
Hepatitis C is mainly spread via contaminated blood. It
can be passed by the following.
Through contact with an infected person's blood.
Transmission from mother to child (less than 5 per cent
risk).
The virus can be contracted by accidental pricking with a
contaminated needle this mainly concerns healthcare
workers.
Sexual transmission among heterosexuals is rare, but
there have been recent concerns regarding possible
sexual transmission among gay men with HIV.
Symptoms
incubation period, from the time of exposure to the virus until
the onset of the disease, is one to six months. Most patients
have no symptoms. Early symptoms include poor appetite,
nausea, aching muscles and joints.
Later symptoms include yellowing of skin, mucous membranes,
and whites of the eyes (jaundice, icterus); light-coloured stools;
and dark urine. Once the late symptoms have developed, in
most cases the patient quickly begins to get better. The disease
typically lasts two to eight weeks.
Chronic or ongoing infection occurs in 60 to 80 per cent of those
infected. These patients generally have no symptoms but some
may complain of fatigue.
Over decades chronic infection can cause scarring of the liver
which can lead to cirrhosis with risk of liver failure and liver
cancer.
PREVENTION
Thank
you